Page last updated: 2024-09-03

ro 43-5054 and arginyl-glycyl-aspartyl-phenylalanine

ro 43-5054 has been researched along with arginyl-glycyl-aspartyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(ro 43-5054)
Trials
(ro 43-5054)
Recent Studies (post-2010)
(ro 43-5054)
Studies
(arginyl-glycyl-aspartyl-phenylalanine)
Trials
(arginyl-glycyl-aspartyl-phenylalanine)
Recent Studies (post-2010) (arginyl-glycyl-aspartyl-phenylalanine)
9003608

Protein Interaction Comparison

ProteinTaxonomyro 43-5054 (IC50)arginyl-glycyl-aspartyl-phenylalanine (IC50)
Integrin beta-3Homo sapiens (human)4.377
Integrin alpha-V Homo sapiens (human)4.1
Integrin alpha-IIbHomo sapiens (human)4.5155

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alig, L; Edenhofer, A; Hadváry, P; Hürzeler, M; Knopp, D; Müller, M; Steiner, B; Trzeciak, A; Weller, T1

Other Studies

1 other study(ies) available for ro 43-5054 and arginyl-glycyl-aspartyl-phenylalanine

ArticleYear
Low molecular weight, non-peptide fibrinogen receptor antagonists.
    Journal of medicinal chemistry, 1992, Nov-13, Volume: 35, Issue:23

    Topics: Amino Acid Sequence; Animals; Dogs; Fibrinogen; Humans; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Structure-Activity Relationship

1992